Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk

Summary

Infections are common and associated with poor outcomes as well as high financial costs after kidney transplantation. Identifying and implementing strategies to reduce infections after kidney transplantation is important for improving patient outcomes. This study seeks to determine the feasibility of body surface area-based dosing of mycophenolate compared to standard dosing of mycophenolate in a pilot randomized controlled trial.

Timeline

Start

2022-07

Primary completion

2023-01

Completion

2023-05

Outcome

Outcome not reported

Stopped (Business): “Study has never started as sponsor did not approve for funding.”

Drugs

Indications